-
Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study
prnasia
December 07, 2020
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncology, announced that the ...
-
BioNTech, Fosun Pharma initiate Covid-19 vaccine candidate trial in China
pharmaceutical-technology
November 27, 2020
BioNTech and Shanghai Fosun Pharmaceutical (Fosun Pharma) have initiated Phase II clinical trial of their lead mRNA Covid-19 vaccine candidate, BNT162b2, in Taizhou and Lianshui, Jiangsu Province, China.
-
New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials
prnasia
November 26, 2020
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the release of the 2020 Centre for Medicines Research (CMR) International Pharmaceutical Clinical Factbook.
-
City of Hope begins phase 1 clinical trial of Covid-19 vaccine candidate
pharmaceutical-business-review
November 26, 2020
City of Hope, the US-based independent biomedical research and treatment centre, has commenced phase 1 clinical trial to evaluate its first SARS-CoV-2 investigational vaccine.
-
FDA approves first treatment for rare paediatric genetic diseases
europeanpharmaceuticalreview
November 26, 2020
Zokinvy (lonafarnib) capsules have been approved for the treatment of Hutchinson-Gilford progeria syndrome and certain progeroid laminopathies in patients over one year old.
-
Lonza Congratulates Moderna on Interim Phase 3 Clinical Trial Data
americanpharmaceuticalreview
November 26, 2020
Lonza has released the following statement congratulating Moderna on its recent clinical trial:“We congratulate Moderna on this important milestone, which represents a significant scientific achievement and serves as a testament to Moderna’s commitment ..
-
Celltrion concludes enrolment for Phase II clinical trial of COVID-19 monoclonal treatment
expresspharma
November 26, 2020
Celltrion anticipates submission for EUA to the Korean Ministry of Food and Drug Safety (MFDS), conditional on results from the global Phase II pivotal trial.
-
Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19
prnasia
November 24, 2020
Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, New Zealand, has identified several known drug compounds of value in their study for a treatment of Covid-19.
-
BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections
prnewswire
November 19, 2020
BioLineRx Ltd., a clinical-stage biopharmaceutical Company focused on oncology, announced that the Company's lead drug candidate, the CXCR4-inhibitor Motixafortide, will be evaluated in an investigator-initiated clinical trial in patients suffering ...
-
PhRMA announces new principles on clinical trial diversity
europeanpharmaceuticalreview
November 19, 2020
New principles on diversity in clinical trials in the US have been released to address systemic issues that deter people from participating in studies.